Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This Italian guideline discusses the diagnosis and treatment of alopecia areata but reports no new clinical trial results; the authors highlight the need for well-designed studies.

This case study reports the first clinical case of besnoitiosis in two donkeys in Italy, suggesting a wider distribution of the disease in European equids than previously expected.

This guideline summarizes evidence-based and expert-based recommendations for treating androgenetic alopecia, adapted by an Italian expert group in alignment with Italian pharmacological policies.

This study proposes a simple fluorescence method to evaluate hair damage and protection, suggesting that emissive properties of hair can aid in substantiating cosmetic claims.

This pilot study found that cord blood platelet-rich plasma treatment was safe and improved symptoms and sexual function in women with vulvar lichen sclerosus after standard topical corticosteroid treatment.

This case report details a 77-year-old man with Parkinson's disease and androgenic alopecia who underwent deep brain stimulation surgery, involving frontal scalp incisions and subcutaneous wire tunneling.

This review suggests a shift toward genetically informed treatments for male pattern hair loss by integrating genetic insights and pharmacogenetic markers into therapeutic decision-making.

The supplement may improve hair growth and quality in women with mild to moderate hair loss.

This study found that using a pharmacogenetic panel with 26 SNPs can improve treatment outcomes for androgenetic alopecia, as overall response rates to minoxidil, finasteride, and dutasteride were high, and specific genetic markers predicted poor responses to these drugs.

This review discusses genetic and pharmacogenetic insights, along with RNA interference technologies, for developing personalized therapies for androgenetic alopecia, yet presents no new clinical results.

This study identified eight genetic markers associated with androgenetic alopecia, suggesting that these SNPs could influence individualized therapeutic responses and highlight the need for personalized treatment strategies.

This article discusses the topic of non-physician owned practices and reports no new research findings.

This study reported that a natural complex showed good efficacy in improving hair loss in both male and female androgenetic alopecia over six months.

This review discusses the potential benefits of nonantibiotic macrolides for treating inflammatory skin disorders and reports no new clinical results.

This study found that adjuvant docetaxel treatment for breast cancer at cumulative doses of 400 mg/m² or higher is associated with a 10% prevalence of persistent alopecia leading to wig use, but this was completely prevented with scalp cooling.

This case report describes a 33-year-old woman whose unilateral occipital pain and localized alopecia were only responsive to onabotulinumtoxin A, suggesting it might be a form of cephalalgia alopecia or nummular headache.

This case report describes a 9-year-old girl with pseudonits and highlights frequent challenges in correctly diagnosing this condition.

This case study describes the successful use of recombinant feline interferon-omega in managing feline chronic gingivostomatitis syndrome in cats with type II diabetes, where long-acting corticosteroids are contraindicated.

Finasteride and baicalin in phospholipid vesicles effectively promote hair growth and increase follicle count.

This review discusses the therapeutic potential and safety of bioidentical recombinant human epidermal growth factor (rhEGF) for various skin and mucosa conditions and reports no new clinical results.

This study presents two cases where intralesional methotrexate combined with ablative fractional CO2 laser treatment resulted in excellent outcomes for refractory alopecia areata.

The researchers reported that intralesional botulinum toxin A effectively alleviated pain associated with cutaneous leiomyomas in a patient with hereditary leiomyomatosis and renal cell cancer syndrome, with repeated treatments every three months maintaining pain relief over 1.5 years.

This study evaluated the 308-nm excimer laser as an adjuvant treatment for frontal fibrosing alopecia and found it may stabilize hairline recession and improve erythema and perifollicular hyperkeratosis, with transient erythema as the only reported adverse effect.

This article questions whether frontal fibrosing alopecia and fibrosing androgeneic patterned hair loss are overlapping conditions or stages of the same process, calling for further research to clarify their underlying factors.

This chapter examines how hormonal changes during the postpartum period, alongside various external factors, impact mother and infant well-being, addressing challenges like postpartum depression, fatigue, and healthcare access, while stressing the need for improved medical training focused on maternal and fetal health.

Hair transplants improve self-esteem and quality of life in women with hair loss.

This abstract highlights that female androgenetic alopecia affects a significant portion of both premenopausal and postmenopausal women, causing considerable psychological distress, yet there are limited treatment options available. Results are not reported.

This case study reported significant hair regrowth in a 67-year-old woman with telogen effluvium following SARS-CoV-2 infection after treatment with a combination of active agents, laser therapies, and medications.

This review discusses the characteristics and diagnostic challenges of fibrosing alopecia pattern distribution, proposing an algorithm for hair transplantation, but reports no new clinical results.